Literature DB >> 21596858

Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3.

Loukas Moutsianas1, Victor Enciso-Mora, Yussanne P Ma, Stephen Leslie, Alexander Dilthey, Peter Broderick, Amy Sherborne, Rosie Cooke, Alan Ashworth, Anthony J Swerdlow, Gilean McVean, Richard S Houlston.   

Abstract

Since an association between the human leukocyte antigen (HLA) region and Hodgkin lymphoma (HL) was first reported in 1967, many studies have reported associations between HL risk and both single nucleotide polymorphism (SNP) and classic HLA allele variation in the major histocompatibility complex. However, population stratification and the extent and complexity of linkage disequilibrium within the major histocompatibility complex have hindered efforts to fine-map causal signals. Using SNP data to impute alleles at classic HLA loci, we have conducted an integrated analysis of HL risk within the HLA region in 582 early-onset HL cases and 4736 controls. We confirm that the strongest signal of association comes from an SNP located in the class II region, rs6903608 (odds ratio [OR] = 1.79, P = 6.63 × 10(-19)), which is unlikely to be driven by association to HLA-DRB, DQA, or DQB alleles. In addition, we identify independent signals at rs2281389 (OR = 1.73, P = 6.31 × 10(-13)), a SNP that maps closely to HLA-DPB1, and the class II HLA allele DQA1*02:01 (OR = 0.56, P = 1.51 × 10(-7)). These data suggest that multiple independent loci within the HLA class II region contribute to the risk of developing early-onset HL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21596858     DOI: 10.1182/blood-2011-03-339630

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

Review 2.  Candidate gene association studies and risk of Hodgkin lymphoma: a systematic review and meta-analysis.

Authors:  Amit Sud; Kari Hemminki; Richard S Houlston
Journal:  Hematol Oncol       Date:  2015-06-05       Impact factor: 5.271

3.  MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Mari Malkki; Theodore A Gooley; Stephen R Spellman; Michael D Haagenson; Mary M Horowitz; Tao Wang
Journal:  Sci Transl Med       Date:  2012-07-25       Impact factor: 17.956

4.  Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.

Authors:  Annemieke W J Opstal-van Winden; Hugoline G de Haan; Michael Hauptmann; Marjanka K Schmidt; Annegien Broeks; Nicola S Russell; Cécile P M Janus; Augustinus D G Krol; Frederieke H van der Baan; Marie L De Bruin; Anna M van Eggermond; Joe Dennis; Hoda Anton-Culver; Christopher A Haiman; Elinor J Sawyer; Angela Cox; Peter Devilee; Maartje J Hooning; Julian Peto; Fergus J Couch; Paul Pharoah; Nick Orr; Douglas F Easton; Berthe M P Aleman; Louise C Strong; Smita Bhatia; Rosie Cooke; Leslie L Robison; Anthony J Swerdlow; Flora E van Leeuwen
Journal:  Blood       Date:  2018-12-20       Impact factor: 25.476

5.  Genome-wide homozygosity signature and risk of Hodgkin lymphoma.

Authors:  Amit Sud; Rosie Cooke; Anthony J Swerdlow; Richard S Houlston
Journal:  Sci Rep       Date:  2015-09-22       Impact factor: 4.379

6.  A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis.

Authors:  Stephan Weidinger; Saffron A G Willis-Owen; Yoichiro Kamatani; Hansjörg Baurecht; Nilesh Morar; Liming Liang; Pauline Edser; Teresa Street; Elke Rodriguez; Grainne M O'Regan; Paula Beattie; Regina Fölster-Holst; Andre Franke; Natalija Novak; Caoimhe M Fahy; Mårten C G Winge; Michael Kabesch; Thomas Illig; Simon Heath; Cilla Söderhäll; Erik Melén; Göran Pershagen; Juha Kere; Maria Bradley; Agne Lieden; Magnus Nordenskjold; John I Harper; W H Irwin McLean; Sara J Brown; William O C Cookson; G Mark Lathrop; Alan D Irvine; Miriam F Moffatt
Journal:  Hum Mol Genet       Date:  2013-07-25       Impact factor: 6.150

7.  Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.

Authors:  Paul C D Johnson; Karen A McAulay; Dorothy Montgomery; Annette Lake; Lesley Shield; Alice Gallagher; Ann-Margaret Little; Anila Shah; Steven G E Marsh; G Malcolm Taylor; Ruth F Jarrett
Journal:  Int J Cancer       Date:  2015-02-20       Impact factor: 7.396

8.  Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.

Authors:  Joseph Vijai; Tomas Kirchhoff; Kasmintan A Schrader; Jennifer Brown; Ana Virginia Dutra-Clarke; Christopher Manschreck; Nichole Hansen; Rohini Rau-Murthy; Kara Sarrel; Jennifer Przybylo; Sohela Shah; Srujana Cheguri; Zsofia Stadler; Liying Zhang; Ora Paltiel; Dina Ben-Yehuda; Agnes Viale; Carol Portlock; David Straus; Steven M Lipkin; Mortimer Lacher; Mark Robson; Robert J Klein; Andrew Zelenetz; Kenneth Offit
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917

9.  The association of HLA-class I and class II with Hodgkin's lymphoma in Iranian patients.

Authors:  Arezou Sayad; Mohammad Taghi Akbari; Mahshid Mehdizadeh; Abolfazl Movafagh; Abbas Hajifathali
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411

10.  Imputing amino acid polymorphisms in human leukocyte antigens.

Authors:  Xiaoming Jia; Buhm Han; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick J Concannon; Stephen S Rich; Soumya Raychaudhuri; Paul I W de Bakker
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.